Camelot Portfolios’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-637
| Closed | -$49.7K | – | 165 |
|
|
2024
Q2 | $49.7K | Buy |
+637
| New | +$49.7K | 0.03% | 299 |
|
|
2022
Q2 | – | Sell |
-6,155
| Closed | -$408K | – | 212 |
|
|
2022
Q1 | $408K | Sell |
6,155
-5,233
| -46% | -$347K | 0.2% | 139 |
|
|
2021
Q4 | $663K | Buy |
11,388
+3,960
| +53% | +$231K | 0.27% | 124 |
|
|
2021
Q3 | $446K | Buy |
+7,428
| New | +$446K | 0.23% | 123 |
|
|
2016
Q4 | – | Sell |
-6,700
| Closed | -$220K | – | 162 |
|
|
2016
Q3 | $220K | Sell |
6,700
-1,500
| -18% | -$49.3K | 0.12% | 135 |
|
|
2016
Q2 | $248K | Hold |
8,200
| – | – | 0.14% | 120 |
|
|
2016
Q1 | $231K | Hold |
8,200
| – | – | 0.14% | 124 |
|
|
2015
Q4 | $278K | Buy |
+8,200
| New | +$278K | 0.18% | 115 |
|
|
2014
Q4 | – | Sell |
-18,246
| Closed | -$652K | – | 174 |
|
|
2014
Q3 | $652K | Sell |
18,246
-1,982
| -10% | -$70.8K | 0.38% | 76 |
|
|
2014
Q2 | $752K | Buy |
+20,228
| New | +$752K | 0.48% | 65 |
|